Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial

Annals of the Rheumatic Diseases · Elsevier

Аннотация

Publication date: October 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 10 Author(s): Anna-Maria Hoffmann-Vold, Shervin Assassi, Vincent Cottin, Michael Kreuter, Claudia Valenzuela, Marlies S Wijsenbeek, Hui Gu, Madhu Kanakapura, Ivana Ritter, Susanne Stowasser, Gerrit Weimann, Toby M Maher

Читать у издателя →

Похожие статьи